Active rTMS: Clinical Trials

4 trials of Active rTMS, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 recruiting, 1 withdrawn. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1

Follow Active rTMS: new trials by email Literature Review of Active rTMS trials Research Report on Active rTMS

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Pharmacological Stress and rTMS on Executive Function in Opioid Use Disorder
Yohimbine + Hydrocortisone, Active rTMS, Placebo - Opioid Use Disorder
Phase 2Not yet recruitingWayne State University202026-10-012025-12-30
Neuroimaging Correlates and Feasibility of Transcranial Magnetic Stimulation (TMS) to Improve Smoking Cessation Outcomes in Veterans With Comorbid PTSD
active repetitive transcranial magnetic stimulation, sham repetitive transcranial magnetic stimulation, cognitive behavioral therapy for smoking cessation - Tobacco Use Disorder
Phase 2RecruitingVA Office of Research and Development502023-10-312026-02-18
Using rTMS to Explore Neural Mechanisms of Stress-Induced Opioid Use
Placebo oral tablet, Yohimbine + Hydrocortisone, sham rTMS - Stress, Opioid-use Disorder
Phase 2WithdrawnWayne State University2023-04-102023-04-13
A Preliminary Investigation of Pre-Frontal Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Cannabis Use Disorder
Active rTMS, Sham rTMS - Cannabis Use Disorder
Phase 2CompletedStanford University722017-08-012023-08-09

Conditions studied

Opioid-Related Disorders (2)  ·  Tobacco Use Cessation (1)  ·  Tobacco Use Disorder (1)

Sponsors

Wayne State University (2)  ·  Stanford University (1)  ·  VA Office of Research and Development (1)

Countries

United States (3)

Top investigators

Gregory Sahlem, MD (1)  ·  Jonathan R Young, MD (1)  ·  Mark Greenwald, PhD (1)

NIH funding

K23DA043628 (1)